Life Sciences
Top stories summarized by our editors
2/21/2018

Takeda Pharmaceutical will develop and commercialize with Wave Life Sciences nucleic acid treatments indicated for central nervous system diseases. Under the terms of the deal, Wave receives an upfront payment of $170 million, and Takeda gets an option to co-develop and co-commercialize Wave's WVE-120101, WVE-120102 and WVE-3972-01, as well as for a preclinical program targeting ataxin 3 for the treatment of spinocerebellar ataxia type 3.

Full Story:
BioCentury
2/21/2018

Orthotaxy, a French company that develops software-enabled surgery technologies, was acquired by Johnson & Johnson through its French affiliate Apsis for undisclosed terms. J&J is aiming to expand the application of Orthotaxy's early-stage robotic-assisted surgery technology for total and partial knee replacement to include other orthopedic surgeries and hopes to develop a solution that is cost-effective, easy to use and saves time in various care settings.

More Summaries:
Johnson & Johnson, Orthotaxy
2/21/2018

About 89% of scientists from the American Association for the Advancement of Science say crops improved by modern biotechnology are safe for human consumption. Recent research showed that no differences have been found that implicate a higher risk to human health and safety from biotech foods versus their nonbiotech counterparts.

Full Story:
ZME Science
2/21/2018

An addition of $1.5 billion to an existing share repurchasing plan of Baxter was approved by the company's board of directors, bringing the repurchase authority to $2.3 billion. Share repurchasing will be done through private transactions at amounts and times established by the company or in the open market.

Full Story:
MassDevice (Boston)
More Summaries:
Baxter
2/21/2018

Medtronic's diabetes division saw a 17% increase in sales during the fiscal third quarter ending Jan. 26 and accounted for about 8% of the company's revenue after the MiniMed 670G system's completion of a priority access program. The company, which saw a shortfall in the supply of sensors for its diabetes devices, eyes market expansion with more products built on the same sensing technology and believes it can now meet future demand.

More Summaries:
Medtronic
2/21/2018

The Fraunhofer Centre for Applied Photonics and Mologic are working together to create a rapid, point-of-care test that will combine microfluidics and nanophotonic waveguides for the diagnosis of bacterial urinary tract infections and related antibiotic susceptibility in primary care settings. The project, which will be supported with $1.3 million in funding from SBRI Healthcare, involves other partners, including the University of Strathclyde, Kelvin Nanotechnology, Wideblue and Barclay Medical Practice.

More Summaries:
Fraunhofer Centre, UTI Dx, Mologic
2/21/2018

Scott Drake, a director at AtriCure, was tapped to serve as chairman of the board at the company beginning in May. Drake, former CEO of Spectranetics, will succeed Richard Johnston, who is retiring from the board.

More Summaries:
AtriCure, Scott Drake
2/21/2018

The Dario blood glucose monitoring system is now on the Amazon marketplace, giving DarioHealth more purchasing and shipping options. The system synchronizes with Dario's diabetes management app and allows diabetes patients to track their glucose levels through the day by connecting to a mobile device through a headphone jack.

More Summaries:
Amazon, DarioHealth
2/21/2018

The FDA granted Siemens Healthineers clearance to market its GOKnee3D MRI software application, which is available for the company's MAGNETOM Aera 1.5T and MAGNETOM Skyra 3T MRI systems. The application, which Siemens aims to roll out for more of its MRI scanners in the future, allows for a 10-minute push-button diagnostic 3D knee exam and comes with machine learning- and artificial intelligence-based automated field-of-view adaptation.

2/21/2018

Anthropology professor Trudy Turner's study of monkeys began with population genetics studies that led to a larger study of simian immunodeficiency virus, which is similar to HIV but does not cause similarly devastating symptoms. Researchers have build a substantial biobank, and the international study might lead to insights about HIV as well as other diseases that affect human and nonhuman primates.

More Summaries:
HIV, Immunodeficiency